Literature DB >> 1385153

Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen.

Y Liu1, B Jones, W Brady, C A Janeway, P S Linsley, P S Linley.   

Abstract

The B cell activation antigen B7/BB1 has been shown to co-stimulate growth of human T cells by binding the T cell molecule CD28. In mice, the heat-stable antigen (HSA) has also been shown to act as a co-stimulator for T cell growth. In this study, we have evaluated the contributions of B7 and HSA to the co-stimulatory activity of antigen-presenting cells (APC). Mouse B7 provides co-stimulatory activity for murine CD4 T cells in anti-CD3-induced proliferation. Human CTLA4Ig, a chimeric molecule comprising the extracellular region of CTLA-4 fused to an immunoglobulin C gamma fragment, binds to murine B7. We, therefore, use human CTLA4Ig and the hamster anti-HSA monoclonal antibody 20C9 to analyze the relative contributions of B7 and HSA to the co-stimulatory activity of murine spleen APC. Our data reveal that both murine B7 and HSA are expressed by dendritic cells and by low-density spleen B cells. Either CTLA4Ig alone or anti-HSA alone inhibited CD4 T cell proliferation to anti-CD3 by > 90%, while CTLA4Ig and anti-HSA together were far more efficient in inhibiting clonal expansion of CD4 T cells. These results demonstrate that functionally defined co-stimulation involves at least B7 and HSA and suggest that signals delivered by B7 and HSA synergize in promoting T cell growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385153     DOI: 10.1002/eji.1830221115

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  47 in total

1.  Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.

Authors:  Jonathan J Miner; Lindsey E Cook; Jun P Hong; Amber M Smith; Justin M Richner; Raeann M Shimak; Alissa R Young; Kristen Monte; Subhajit Poddar; James E Crowe; Deborah J Lenschow; Michael S Diamond
Journal:  Sci Transl Med       Date:  2017-02-01       Impact factor: 17.956

2.  Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.

Authors:  G A Holländer; E Castigli; R Kulbacki; M Su; S J Burakoff; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

3.  Expression of HIS50 Ag: a rat homologue of mouse heat-stable antigen and human CD24 on B lymphoid cells in the rat.

Authors:  M H Hermans; G J Deenen; N De Boer; W Bo; F G Kroese; D Opstelten
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.

Authors:  M Harada; T Okamoto; K Omoto; K Tamada; M Takenoyama; C Hirashima; O Ito; G Kimura; K Nomoto
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Identification of a novel dendritic cell surface antigen defined by carbohydrate specific CD24 antibody cross-reactivity.

Authors:  L A Williams; A D McLellan; K L Summers; R V Sorg; D B Fearnley; D N Hart
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

6.  Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes.

Authors:  Y Liu; R H Wenger; M Zhao; P J Nielsen
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

7.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

Authors:  R S McHugh; S N Ahmed; Y C Wang; K W Sell; P Selvaraj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Reduced lysis by CD8+ cytotoxic T cells in mixed lymphocyte reactions induced via CD4+ T cells exposed to chemically modified antigen presenting cells.

Authors:  L Corlett; D H Davies
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  CD24 is a genetic modifier for risk and progression of multiple sclerosis.

Authors:  Qunmin Zhou; Kottil Rammohan; Shili Lin; Nikki Robinson; Ou Li; Xingluo Liu; Xue-feng Bai; Lijie Yin; Bruce Scarberry; Peishuang Du; Ming You; Kunliang Guan; Pan Zheng; Yang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation.

Authors:  D N Hart; G C Starling; V L Calder; N S Fernando
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.